Company / Shareholders' Equity
BIOTRICITY INC. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$32.0M
FY2025
5-year range
-$32.0M / -$2.1M
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BIOTRICITY INC. reports negative total equity of -$32M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$32M in FY2025.
Declined from -$20M to -$32M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- BIOTRICITY INC.'s shareholders' equity has declined for 3 consecutive years.
- In FY2025, shareholders' equity decreased 1.7% year-over-year.
- Peak shareholders' equity was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -22.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$32.0M | -1.7% |
| FY2024 | -$31.5M | -58.6% |
| FY2023 | -$19.8M | -825.3% |
| FY2022 | -$2.1M | +68.6% |
| FY2021 | -$6.8M | -127.7% |
| FY2020 | -$3.0M | -68.8% |
| FY2019 | -$1.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026